Beneficial Bacterial Biofilms

Biofilms in the Food Environment

Volumn , Issue , 2007, Pages 153-166

  Reid, Gregor ^a   Kirjavainen, Pirkka ^a,b   Richardson, Bryan ^c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Beneficial bacterial biofilms; Displacement of biofilms; Formation of biofilms; Microbes; Organisms

Indexed keywords

EID: 84889472503     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470277782.ch7     Document Type: Chapter

References (66)

1. Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, Wold AE. 1996. A mannosespecific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol. 62(7):224451.
2. Anderson GG, Martin SM, Hultgren SJ. 2004. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect. 6(12):1094-1101.
3. Anukam KC, Osazuwa EO, Ahonkhai I, Reid G. 2006. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin City, Nigeria. Sex. Transm. Dis. 33(1):59-62.
4. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101(44):15718-15723.
5. Brummel T, Ching A, Seroude L, Simon AF, Benzer S. 2004. Drosophila lifespan enhancement by exogenous bacteria. Proc Natl Acad Sci U S A 101(35):12974-12979.
6. Burton JP, Cadieux P, Reid G. 2003. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 69:97-101.
7. Busscher HJ, Bos R, van der Mei HC. 1995. Initial microbial adhesion is a determinant for the strength of biofilm adhesion. FEMS Microbiol Lett 128(3):229-234.
8. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, Corneli RB, Ferretti E, Gulino A, Grasso F, De Simone C, Di Mario U, Falorni A, Boirivant M, Dotta F. 2005. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48(8):1565-1575.
9. Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW. 1985. Competitive exclusion of uropathogens from uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47:84-89.
10. Conway PL, Kjelleberg S. 1989. Protein-mediated adhesion of Lactobacillus fermentum strain 737 to mouse stomach squamous epithelium. J Gen Microbiol 135(Pt 5):1175-1186.
11. Dandona P, Aljada A, Bandyopadhyay A. 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7.
12. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. 2002. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82(2):103-108.
13. Eisen A, Reid G. 1989. Effect of culture media on Lactobacillus hydrophobicity and electrophoretic mobility. Microbial Ecol 17(1):17-25.
14. Erdeve O, Tiras U, Dallar Y. 2004. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatr 50(4):234-236.
15. FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report. http://www.fao.org/es/ESN/Probio/probio.htm.
16. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. 2002. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 68(1):219-226.
17. Filoche SK, Anderson SA, Sissons CH. 2004. Biofilm growth of Lactobacillus species is promoted by Actinomyces species and Streptococcus mutans. Oral Microbiol Immunol 19(5):322-326.
18. Free RH, Busscher HJ, Elving GJ, van der Mei HC, van Weissenbruch R, Albers FW. 2001. Biofilm formation on voice prostheses: in vitro influence of probiotics. Ann Otol Rhinol Laryngol 110(10):946-951.
19. Gardiner G, Heinemann C, Baroja ML, Bruce AW, Beuerman D, Madrenas J, Reid G. 2002. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int Dairy J 12(2-3):191-196.
20. Gibbons RJ, Hay DI, Childs WC 3rd, Davis G. 1990. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces. Arch Oral Biol 35(Suppl):107S-114S.
21. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthesy-Theulaz IE. 2004. Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 72(4):2160-2169.
22. Heinemann C, Van Hylckama Vlieg JET, Janssen DB, Busscher HJ, van der Mei HC, Reid G. 2000. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 inhibiting Enterococcus faecalis 1131 adhesion. FEMS Microbiol Lett. 190:177-180.
23. Heinemann C, Reid G. 2005. Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol 51(9):777-781.
24. Henke JM, Bassler BL. 2004. Bacterial social engagements. Trends Cell Biol 14(11):648-656.
25. Hoyos AB. 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3(4):197-202.
26. Hsu LY, Minah GE, Peterson DE, Wingard JR, Merz WG, Altomonte V, Tylenda CA. 1990. Coaggregation of oral Candida isolates with bacteria from bone marrow transplant recipients. J Clin Microbiol 28(12):2621-2626.
27. Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, Duffy JE, Beyenal H, Lewandowski Z. 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 171(8):4329-4339.
28. Jump RL, Levine AD. 2004. Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease. Inflamm Bowel Dis 10(4):462-478.
29. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357(9262):1076-1079.
30. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. 2003. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361(9372):1869-1871.
31. Kelly MC, Mequio MJ, Pybus V. 2003. Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis. Infect Dis Obstet Gynecol 11(3):147-156.
32. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. 2002. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51(1):51-55.
33. Kolenbrander PE. 2000. Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 54:413-437.
34. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. 2002. Communication among oral bacteria. Microbiol Mol Biol Rev 66(3):486-505.
35. Lamont RJ, El-Sabaeny A, Park Y, Cook GS, Costerton JW, Demuth DR. 2002. Role of the Streptococcus gordonii Ssp B protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates. Microbiology 148(Pt 6):1627-1636.
36. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. 2004. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53(11):1610-1616.
37. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. 2003. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52(6):827-833.
38. Mai V. 2004. Dietary modification of the intestinal microbiota. Nutr Rev 62(6 Pt 1):235-242.
39. Matsuzaki T, Nagata Y, Kado S, Uchida K, Kato I, Hashimoto S, Yokokura T. 1997. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 105(8):643-649.
40. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Gilbert P. 2003. Growth and molecular characterization of dental plaque microcosms. J Appl Microbiol 94(4):655-664.
41. McGroarty JA. 1994. Cell surface appendages of lactobacilli. FEMS Microbiol Lett 124(3):405-409.
42. McGroarty JA, Lee V, Reid G, Bruce AW. 1992. Modulation of adhesion of uropathogenic Enterococcus faecalis to human epithelial cellsin vitro by Lactobacillus species. Microbial Ecol Health Dis 5:309-314.
43. Ma D, Forsythe P, Bienenstock J. 2004. Live Lactobacillus reuteri is essential for the inhibitory effect on tumour necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72:5308-5314.
44. Miettinen M, Lehtonen A, Julkunen I, Matikainen S. 2000. Lactobacilli and streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol 164(7):3733-3740.
45. Miniello VL, Moro GE, Armenio L. 2003. Prebiotics in infant milk formulas: new perspectives. Acta Paediatr Suppl 91(441):68-76.
46. Morelli L, Zonenenschain D, Del Piano M, Cognein P. 2004. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 38(6 Suppl):S107-S110.
47. Nase L, Hatakka K, Savilahti E, Saxelin M, Ponka A, Poussa T, Korpela R, Meurman JH. 2001. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 35(6):412-420.
48. Nopchinda S, Varavithya W, Phuapradit P, Sangchai R, Suthutvoravut U, Chantraruksa V, Haschke F. 2002. Effect of Bifidobacterium Bb12 with or without Streptococcus thermophilus supplemented formula on nutritional status. J Med Assoc Thai 85(Suppl 4):S1225-S1231.
49. Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E. 2004. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol Immunol 48(7):497-500.
50. Probert HM, Gibson GR. 2002. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol 3(2):23-27.
51. Reid G. 2005. Colonization of the vagina and urethral mucosa. In Colonization of Mucosal Surfaces ( JP Nataro, PS Cohen, HLT Mobley, JNWeiser, Editors). ASM Press,Washington, DC, pp. 431-448.
52. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. 2001a. Oral probiotics can resolve urogenital infections. FEMS Microbiol. Immunol 30:49-52.
53. Reid G, Heinemann C, Howard J, Gardiner G, Gan BS. 2001b. Understanding urogenital biofilms and the potential impact of probiotics. Methods Enzymol 336:403-410.
54. Reid G, McGroarty JA, Domingue PAG, Chow AW, Bruce AW, Eisen A, Costerton JW. 1990. Coaggregation of urogenital bacteria in vitro and in vivo. Current Microbiol 20:47-52.
55. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR. 2003. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37(2):105-118.
56. Ren D, Bedzyk LA, Thomas SM, Ye RW, Wood TK. 2004. Gene expression in Escherichia coli biofilms. Appl Microbiol Biotechnol 64(4):515-524.
57. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Tvede M, Weyrehter H, Valerius NH, Paerregaard A. 2002. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 21(5):417-419.
58. Rozanova GN, Voevodin DA, Stenina MA, Kushnareva MV. 2002. Pathogenetic role of dysbacteriosis in the development of complications of type 1 diabetes mellitus in children. Bull Exp Biol Med 133(2):164-166.
59. Salminen S, Gibson GR, McCartney AL, Isolauri E. 2004. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53(9):1388-1389.
60. Saran S, Gopalan S, Krishna TP. 2002. Use of fermented foods to combat stunting and failure to thrive. Nutrition 18(5):393-396.
61. Sbordone L, Bortolaia C. 2003. Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clin Oral Investig 7(4):181-188.
62. Schachtsiek M, Hammes WP, Hertel C. 2004. Characterization of Lactobacillus coryniformis DSM 20001T surface protein Cpf mediating coaggregation with and aggregation among pathogens. Appl Environ Microbiol 70(12):7078-7085.
63. Schwiertz A, Gruhl B, Lobnitz M, Michel P, Radke M, Blaut M. 2003. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 54(3):393-399.
64. Stappenbeck TS, Hooper LV, Gordon JI. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99(24):15451-15455.
65. Vieira HL, Freire P, Arraiano CM. 2004. Effect of Escherichia coli morphogene bol A on biofilms. Appl Environ Microbiol 70(9):5682-5684.
66. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, Deleo FR, Otto M. 2004. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279(52):54881-54886.